Our team is leading the way to identify the best drugs to stop the most deadly cells responsible for cancer metastasis, spread and recurrence.

Executive Team

headshot hi res cropped.jpg

CEO, Director

Cindy Clark, JD

Serial entrepreneur with 25+ years life science experience (drugs, devices, diagnostics, health information technology, combination products), 5 successful exits, multiple successful product launches, $170M+ in public and private funding, license & collaborations valued at $350M+, federal/state grant and pharma business development experience

Board of Directors

goldstein pic.jfif

Chair

Charles Goldstein, PhD, MSE

Retired Senior Vice President R&D Becton Dickinson; Board member Hale and Proteona; Advisor, Johns Hopkins University – Whiting School of Engineering

KK pic.jfif

Director

Konstantinos Konstantopoulos, PhD

William H. Schwarz Professor of Chemical and Biomolecular Engineering, Biomedical Engineering and Oncology at Johns Hopkins, Project leader NCI-funded JHU Physical Sciences-Oncology Center, PI of multiple NIH R01 grants, numerous awards, serves on editorial boards of several scientific journals.

© 2020 by RecurX Bio, Inc. All Rights Reserved in all countries. RecurX Bio is a trademark of RecurX Bio, Inc.